AIMCA
VYGR icon

Alberta Investment Management Corp (AIMCo)’s Voyager Therapeutics VYGR Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-32,900
Closed -$415K – 1148
2020
Q2 		$415K Buy
+32,900
New +$383K 0.01% 878
2020
Q1 		– Sell
-55,200
Closed -$770K – 1046
2019
Q4 		$770K Buy
+55,200
New +$802K 0.01% 722

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s VYGR Position: Q3 2020 in Review

Alberta Investment Management Corp (AIMCo) sold out of Voyager Therapeutics (VYGR) in Q3 2020, closing a stake of 32,900 shares — an estimated $415K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in VYGR in Q4 2019 and held it in 2 quarters. The position peaked at $770K in Q4 2019. 110 funds tracked by Wall St. Rank hold VYGR as of Q3 2020.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Voyager Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 32,900 Voyager Therapeutics shares in Q3 2020, an estimated $415K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Voyager Therapeutics in Q4 2019 and held it in 2 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Voyager Therapeutics position peaked at $770K in Q4 2019.
  • 110 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2020.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2020, filed 26 Oct 2020.